Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 9, 2024VaccinesOpen Access

Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJimmie BullockTHThomas E. HickeyFrederick National Laboratory for Cancer ResearchTKTroy J. KempFrederick National Laboratory for Cancer Research

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bullock et al. (2024) studied this question.

synapsesocial.com/papers/68e6ad90b6db64358762f2bbhttps://doi.org/10.3390/vaccines12050516
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Novel Anti-nucleocapsid Antibody Avidity Method for Identifying SARS-CoV-2 Reinfections2024 · 6 citations
  2. 2Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategy2024 · 6 citations
  3. 3Viral-Induced Enhanced Disease Illness2018 · 141 citations
  4. 4Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans2021 · 274 citations